Brief: Tuhura Biosciences Inc Enters At The Market Offering Agreement With H.C. Wainwright & Co.
08/04/2026 21:38
April 8 (Reuters) - TuHURA Biosciences Inc HURA.O: TUHURA BIOSCIENCES INC - ENTERS AT THE MARKET OFFERING AGREEMENT WITH H.C. WAINWRIGHT & CO. - SEC FILING TUHURA BIOSCIENCES INC - MAY OFFER COMMON STOCK UP TO $50 MILLION AGGREGATE - SEC FILING Source text: [ID:n0001193125-26-147748] Further company coverage: HURA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on TuHURA Biosciences
See all newsBrief: Tuhura Biosciences Receives Key U.S. Patent For Its Groundbreaking Delta Opioid Receptor Antibody Drug Conjugate Technology
TuHURA Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Tuhura Biosciences Reports Second Quarter 2026 Financial Results And Provides A Corporate Update
TuHURA Biosciences Inc expected to post a loss of 14 cents a share - Earnings Preview
Brief: Tuhura Biosciences Inc Enters At The Market Offering Agreement With H.C. Wainwright & Co.